In recent years, there has been an increased focus on the importance of health. People are looking for ways to improve their health and live a longer, more
productive life. There are many different places that people can go to work on their health, but some are better than others. Here is a list of the top six places
to work on your health.
1) MEDICAL SPA
A medical spa is a place where people can go to improve their health. medical spas offer a variety of services, including skin care, laser hair removal, and body
contouring. They also offer a variety of medical treatments, such as laser surgery and Botox injections.
Medical spas offer a number of benefits to their patients. First, they offer a wide variety of services that can help people improve their health. Second, they offer
a number of medical treatments that can help people address specific health concerns. Third, they offer a relaxing environment where people can come to improve their
health and wellbeing. No matter if you're looking for a medical spa in Alexandria, VA, New York, or any other state, they can be a great place to work on your health.
Plus, if you're looking for a place to get health insurance, they can also help you with that.
In response to new research that revealed inequality in menopause support with 51 per cent of women from black, Asian and minority ethnic backgrounds,
Holland & Barrett, the UK's leading health and wellness retailer, has decided to continue its menopause campaign work to make "every menopause matter".
A quarter of women (26 per cent) from minority ethnic communities say they find it difficult to access menopause support relevant to their specific backgrounds.
Alongside support from Olympian and menopause campaigner, Michelle Griffith Robinson and expert, Meera Bhogal, the retailer is launching several new initiatives
to make its information and support on menopause more inclusive by offering more diverse and personalised advice and content, tailored to different needs.
Almost a third (31 per cent) believe being able to speak to a female healthcare professional of the same ethnicity as them would have made a difference to their
menopause experience. Fifteen per cent go as far as saying that communicating in their native language would have made a positive difference.
Based on these findings, Holland and Barrett is the first retailer to launch a free, multi-language menopause online consultation service. The service will
see trained H&B menopause advisors offering guidance and symptom support in multiple languages, starting with Hindi, Urdu, Gujarati and Punjabi.
Drug addiction poses a serious challenge since it impacts one's physical and mental health. However, the good news is that individuals who complete a drug
rehabilitation program can overcome this problem. If you are interested in providing rehab services, there are a couple of things you should know. Read on to
learn how to operate a rehabilitation clinic flawlessly.
KNOW THE NEEDS OF YOUR CLIENTS
The main purpose of drug rehab is to help different people overcome addictions. It is designed to heal the body and mind from the negative effects of addiction.
It also teaches the affected individuals to learn to live without using substances. Therefore, your first step is to conduct a comprehensive assessment of each
client to formulate a personalized treatment plan. Everyone has unique needs in their recovery journey.
Your rehab program can start with detox which is designed to rid the body of substances, although it does not treat addiction. The person affected undergoes
different therapies during treatment. Therapy helps them deal with the issues that cause substance abuse and teach them healthier ways of life. Various therapies
will be applied throughout the entire treatment process. Therefore, you must choose a suitable therapy for each individual. For instance, motivational interviewing
and cognitive behavioral therapy are the most common.
Addiction is a complex disease that can be difficult to overcome. Many people don't realize how serious addiction is and often don't seek treatment until
it's too late. If you or someone you know is struggling with addiction, it's important to learn as much as you can about the treatment process. This blog post
will discuss six vital things that you should know about addiction treatment.
RESEARCH THE VARIOUS TYPES OF TREATMENTS AVAILABLE
One of the first things you should do when considering addiction treatment is to research the different types of treatments available. There are many different
approaches to treating addiction, and it's important to find one that will work best for you or your loved one. Some common types of addiction treatments include
12-step programs, cognitive-behavioral therapy, detoxification, and medication-assisted treatment. The addiction treatment service providers behind Safe Harbor
Treatment Center suggest that you should also consider the length of treatment, as some programs are more intensive than others. It's important to remember that
no two people are the same, so what works for one person may not work for another. It's important to find a treatment that will address the underlying causes of
addiction and help the individual to develop healthy coping mechanisms.
An alliance of companies has pledged to ensure equitable access to vaccines and treatments for pandemics, as the friction around intellectual property rights
for Covid-19 interventions between the pharmaceutical industry and developing nations endures.
At the heart of the plan is a commitment to set aside part of the production of vaccines and treatments upfront for vulnerable populations in low-income countries
when the next pandemic arises, given how fragmented access to Covid tools has left many populations unprotected.
In order to do better next time - and without knowing which companies will develop the first drugs and vaccines for the next pandemic - having the industry
collectively make this commitment is potentially transformative, said Thomas Cueni, head of the International Federation of Pharmaceutical Manufacturers &
Associations (IFPMA).
The pledge, called the Berlin Declaration, was made on July 19 by members of the global pharmaceutical industry group that include many of the companies involved
in developing Covid interventions, such as AstraZeneca, GSK, Moderna, Pfizer and Merck.
The declaration is not legally binding.
However, if a company that signed on reneges on its vow, it would face grave consequences in the court of public opinion, said Cueni.
NHS chief executive Amanda Pritchard today (March 1) announced a new campaign to promote early detection of cancer, when it is easier to treat.
The campaign, which would run across TV, radio, and social media from Wednesday (March 2), is the first to focus on tackling the fear of cancer rather thanspecific symptoms.
It is in line with the NHS Long Term Plan's commitment to increase cancer detection at an early stage by 2028.
As per the NHS figures, the number of people getting checked for cancer increased by over half a million between December 2020 and December 2021.
Speaking ahead of the launch, Pritchard, said: "We know that the prospect of a cancer diagnosis can be daunting for people and that is exactly why we are launching this potentially lifesaving campaign - we want to allay people's fear about cancer and encourage them to get checked without delay.
The General Pharmaceutical Council (GPhC) has removed a pharmacist from its register who black-marketed 'zolpidem' along with another pharmacist between 2015
and 2016.
Dean Zainool Dookhan, a pharmacist first registered with the Royal Pharmaceutical Society of Great Britain on 18 October 2004 and whose registration was later
transferred to the General Pharmaceutical Council under registration number 2059808, was jailed last year for exporting 20,000 packets of zolpidem to the Caribbean.
While hearing the case on 24-25 May, GPhC's Fitness to Practise Committee stated that "removal of the Registrant's name from the register is the appropriate and
proportionate response to his convictions."
"The public interest includes protecting the public, maintaining public confidence in the profession, and maintaining proper standards of behaviour. The Committee
is entitled to give greater weight to the public interest than the Registrant's own interest in remaining on the register."
"The Committee recognises the sanction has a punitive effect in that the Registrant's ability to practise and earn an income as a pharmacist and 28 his professional
reputation will be curtailed; it will be five years before he can seek restoration to the register. However, that is the price he must pay for failing to comply with the fundamental tenets of his profession."
The Department of Health and Social Care (DHSC) has announced 30 pence increase in prescription charges from £9.35 to £9.65 for each medicine or appliance
dispensed.
Board Chair for England at RPS, Thorrun Govind commented: "This is a kick in the teeth for people in England who are already struggling with rising bills and food
prices.
"Patients groups have warned that people are not collecting prescription medicines due to cost and pharmacists are seeing this worrying trend first-hand.
"A Government impact assessment noted the risk of adverse effects of people not taking their medicines, resulting in future health problems for the individual,
potential hospital admissions, and a subsequent cost to the NHS.
"This decision seems to prioritise revenue generation over ill-health prevention and undermines the principle of an NHS free at the point of use.
The Pharmacists' Defence Association (PDA) has undertaken an additional survey of pharmacists employed in the NHS, before deciding to hold their first-ever
ballot for industrial action.
The PDA has more than 7,000 NHS-employed pharmacists in membership and the union is actively considering balloting those members regarding strike action.
The association said: "The experience of some other unions has shown that the government's restrictive rules, designed to make it difficult for working people to
lawfully take industrial action, means trade unions should test members' strength of feeling before balloting."
"Trade unions are not only forced to rely upon postal ballots, but for lawful industrial action to be taken, the result must also meet three tests- at least 50% of
eligible voters must vote; at least 40% of eligible voters must vote 'yes' and a majority of votes must be for 'yes'."
The association is asking members in England, Northern Ireland and, Wales to show if their collective wish, insignificant enough strength, is for strike action. PDA
has emailed the survey to all its members in the NHS in the three nations and will close on Tuesday 3 January.
The UK government's community diagnostic centre programme, which was first launch in July 2021, is helping cut waiting lists, and speed up diagnoses and
treatments for NHS patients.
As of November 2023, a total of 6.1 million vital checks have been carried out at community diagnostic centres (CDCs) across England, according to a joint statement
released by the Department of Health and Social Care (DHSC) and NHS England.
Under the £2.3 billion programme, 141 CDCs have been opened across the country in a variety of settings including shopping centres, university campuses and football
stadiums, offering patients a wide range of diagnostic tests closer to home.
The government has set a target to open 160 CDCs by March 2025, with many expected to open ahead of schedule.
Reacting to recommendations from a UK-first independent review, the Department of Health and Social Care (DHSC) has outlined action to tackle potential
bias in the design and use of medical devices.
Professor Dame Margaret Whitehead, professor of public health at the University of Liverpool, was appointed to lead the review, which focused on three
areas - optical devices such as pulse oximeters, AI-enabled devices, and polygenic risk scores (PRS) in genomics.
The DHSC commissioned the medical devices review after concerns were raised that pulse oximeters - widely used during the COVID-19 pandemic to monitor blood
oxygen levels - were not as accurate for patients with darker skin tones. There were worries that this could cause delays in treatment if dangerously low oxygen
levels in such patients were missed.
However, no evidence was found from NHS studies indicating that this differing performance had an impact on patient care.
Accepting the report's conclusions, the DHSC has committed to several actions, such as ensuring the safe use of pulse oximeter devices across a range of skin
tones within the NHS and eliminating racial bias from data sets employed in clinical studies.
The severity of the ADHD medication shortage in the UK has been exposed as former Hollywood extra Lee Cato revealed that he was forced to quit his job but
hasn't been able to access his medicine.
A resident of Berkhamsted, Hertfordshire, Lee had worked as a film extra in big movies like 'Thor' and 'Edge of Tomorrow'.
The 48-year-old told Mirror that he has been taking Concerta for years to manage ADHD symptoms, but he hasn't been able to get the drug or any alternatives for
over a month.
He said that he first experienced shortages of the medicine in December 2023 but was initially able to take Delmosart, which he took to maintain focus despite
experiencing its side effects such as headaches, nausea, tooth erosion, and a dry mouth.
But now, he can't get access to any of these ADHD drugs as "they're completely out-of-stock and it's been over a month now."
His chemist also tried to get hold of his medication but failed.
Thousands of cancer patients in England are set to gain fast-tracked access to personalised cancer vaccine trials through a new National Health Service(NHS)
initiative, the Cancer Vaccine Launch Pad.
This groundbreaking service aims to find new life-saving treatments by matching eligible patients with clinical trials across the country.
The first patient to receive a personalised vaccine for bowel cancer is Elliot Phebve, a 55-year-old lecturer, treated at University Hospitals Birmingham NHS
Foundation Trust.
Phebve, diagnosed through a routine health check, underwent surgery and chemotherapy before joining the trial.
Sponsored by German biotech company BioNTech SE, the colorectal cancer vaccine trial is one of several taking place across NHS trusts.
The University of Oxford's Centre for Research Equity (CfRE) has entered into a historic partnership with the Health and Social Care Research and
Development (HSC R&D) Division in Northern Ireland to advance health equity across the region and ensure everyone benefits from healthcare advancements.
Unveiled during an event at Parliament Buildings in Stormont Estate on Wednesday, this groundbreaking partnership makes Northern Ireland the first UK region
to partner with CfRE.
Supported by the Department of Health Northern Ireland and key health and social care agencies, the partnership aims to improve health outcomes and reduce
disparities through collaborative research.
Northern Ireland's Health Minister, Mike Nesbitt, highlighted that this new partnership represents "a significant step forward in efforts to address health
inequalities" in the region.
"By bringing together leading experts and resources from across sectors, we can work towards conducting research that truly benefits all of our communities," he
said.
Pharma giant, Pfizer has announced plans to cut 500 jobs at its Sandwich site in Kent, England as part of its ongoing $3.5 billion cost-cutting drive.
The company is also planning to shut its Pharmaceutical Sciences Small Molecule (PSSM) capabilities at the site, a spokesperson of the company told FiercePharma.
However, the Sandwich site will remain open and other functions will continue with "a different size," the spokesperson added.
Currently, around 940 people are employed at the site, which is the location where Pfizer scientists first discovered Viagra.
"We are proud of our heritage of breakthrough science in the UK and we will retain a scientific presence in the U.K. including at our Discovery Park location
in Sandwich," Pfizer's spokesperson confirmed in an email to FiercePharma.
Travelling with medical cannabis can be a complex and often confusing experience, given the diverse legal regulations across different countries and states.
Patients who rely on medical cannabis for their wellbeing need to be well-informed and prepared to ensure a smooth and hassle-free travel experience. This
comprehensive guide covers essential aspects, legal considerations, and practical tips for individuals who use medical cannabis and wish to travel.
Know the Laws
The first and most crucial step before travelling with medical cannabis is to understand the laws and regulations of both the departure and destination locations.
Laws regarding medical cannabis use vary significantly from one country, state, or even city to another. Some places have legalised medical cannabis, while others
strictly prohibit its use. Researching and familiarising oneself with the specific regulations of the destination, transit countries, and the home country is
essential.
Travelling Within the Same Country
When travelling within a country where medical cannabis is legal, patients generally need to carry their prescription information issued by a licensed healthcare
provider. It's advisable to keep medical cannabis in its original packaging, clearly labelled with the patient's name, prescribing physician, and dosage instructions.
Carrying a copy of the relevant laws and regulations can also be helpful in case of any inquiries from authorities. What can be easier than carrying around paperwork,
which could get easily damaged or lost during your travels, is to get a medical card that has a unique QR code on it from Releaf Cannabis, which, when scanned, can
present their prescription information digitally - it has revolutionised the way patients manage their healthcare. This eliminates the need for physical documents
and streamlines the process but also ensures the security and confidentiality of sensitive medical information, offering patients a more efficient and organi
Patients suffering from chronic and episodic migraine attacks are set to benefit from a groundbreaking recommendation by the National Institute for Health
and Care Excellence (NICE) regarding a new medication.
The atogepant, a first-of-its-kind preventive drug for migraine, offers hope for those grappling with this debilitating condition and can be taken orally.
Published as part of the final guidance draft, NICE has greenlit the atogepant, also known as Aquipta and manufactured by AbbVie, as an option for preventing both
chronic and episodic migraines in adults.
Specifically, this recommendation is for individuals who have experienced at least four migraine days per month and have failed to find relief with at least three
previous preventive treatments.
With approximately 4.5 million people in the UK affected by various forms of migraine, this new recommendation marks a significant advancement in migraine management
as the condition significantly impacts patients' day-to-day activities as well as places a heavy burden on the NHS and the wider economy.
NHS England has confirmed the initial sites that will test and implement Martha's Rule in the first phase of the programme.
This follows the announcement in February regarding NHSE funding for the major patient safety initiative for this financial year.
The scheme is named after Martha Mills, who died from sepsis at the age of 13 in 2021. She had been treated at King's College Hospital, London, where a failure
to escalate her to intensive care and a lack of response to her family's concerns about her deteriorating condition contributed to her death.
Martha's Rule aims to provide a consistent and understandable way for patients and families to seek an urgent review if their or their loved one's condition
deteriorates and they are concerned this is not being responded to.
NHS England on Monday (27 May) announced that the scheme will be implemented at 143 hospital sites across the country by March 2025.
There is a clear opportunity for community pharmacists and their teams to lead best practice when it comes to supporting the ongoing health needs of older
people. As the global population continues to age, the demand for specialised healthcare services tailored to the elderly is rapidly increasing. Community
pharmacists, with their accessible locations and frequent interactions with patients, are uniquely positioned to play a pivotal role in addressing this growing need.
The ageing population presents a complex set of health challenges, including multiple chronic conditions, polypharmacy, and increased susceptibility to adverse
drug reactions. Community pharmacists, armed with their extensive knowledge of medications and their effects, can serve as the first line of defence in managing
these issues. By leveraging their expertise, they can implement best practices that not only improve the quality of life for older individuals but also reduce the
burden on the broader healthcare system.
One of the primary areas where community pharmacists can make a significant impact is in medication management. As people age, they often find themselves taking
multiple medications for various conditions. This polypharmacy can lead to dangerous drug interactions, side effects, and compliance issues. Community
pharmacists can lead the way in implementing comprehensive medication reviews, ensuring that each patient's drug regimen is optimised for their specific needs
and minimising potential risks.
In a bid to address the ongoing deficit in staff in the UK's healthcare system, the National Health Service (NHS) has entered into a new workforce agreement
with India.
According to media reports, the healthcare service plans to hire 2,000 doctors from India on a fast-track basis to alleviate this pressing issue.
It is learned that the NHS has set up training centres across many Indian cities such as Mumbai, Bangalore, Nagpur, Delhi, Gurugram, Indore, Mysore, Chennai,
and Calicut to provide postgraduate training for the first batch of doctors.
Post their training period (which ranges from six to 12 months), these doctors will be deployed at hospitals across Britain. They will also be exempted from the
Professional and Linguistic Assessments Board (PLAB) examination that is otherwise mandatory for practising in the country.